Tracers / [18F]DPA-C5yne

[18F]DPA-C5yne

Also written as [18F]DPA-C5yne; [F-18]DPA-C5yne
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
Stage
preclinical
Syntheses indexed
1

What it is

Compound class
pyrazolo[1,5-a]pyrimidine acetamide (DPA-714 fluoroalkynyl analogue)
Target / mechanism
translocator protein 18 kDa (TSPO) PMID 24764161
Clinical application
neuroinflammation imaging (preclinical rat model of acute local neuroinflammation) PMID 24764161
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
HPLC+SPE14-17%>95%24764161
2014 J Labelled Comp Radiopharm
formulated as an i.v. injectable solution using a TRACERLab FX N Pro synthesizer — starting from a 30 GBq [(18)F]fluoride batch (14-17%)

Need this precursor?We can point you to suppliers for [18F]DPA-C5yne, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]DPA-C5yne.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18.